User:Mchport

Elena Beyzarov
Elena Beyzarov (born January 7, 1973) is an American clinical pharmacist and professional medical writer. She is the co-author of "Netter's Illustrated Pharmacology" and author of hundreds of clinical articles on a broad range on pharmacotherapeutic, general health and medical science subjects.

A New York native, Beyzarov earned her BS degree in pharmacy from Arnold and Marie Schwartz College at Long Island University and received her PharmD from the College of Pharmacy at the University of Arkansas. Her career in medical publishing began at Medical Economics, where she authored a broad variety of clinical articles for Drug Topics magazine and continued at MediMedia USA as Scientific Editor and Editor-in-chief of prescribing guides. In 2002, she held an academic appointment as adjunct associate professor of pharmacology in the Department of Professional Nursing at Felician College of New jersey. After deciding to become more involved in clinical practice, she joined Barnabas Health as clinical pharmacist and later as Director of Medical Communications. She currently works as Director of Scientific Affairs at Pharmacy Times. Beyzarov’s medical writing  ranged widely over her career, beginning with her early articles on primary care medicine, obstetrics and gynecology, hematology, oncology and gastroenterology  and continuing with publications on cardiovascular disease, diabetes, asthma, and COPD.

One of her best known contributions is “"Netter's Illustrated Pharmacology" -  an uniquely effective visual presentation of the pharmacotherapeutic relationship between drugs and the human body. Published in 2005, the book provides a broad coverage of both the basic science and clinical applications of pharmacologic principles based on classic images by Frank Netter.

Elena Beyzarov currently lives with her husband and children in New York.

Books

 * Netter’s Illustrated Pharmacology, co-written with Robert B. Raffa and Scott M.      Rawls, MediMedia,Inc. (2005,  ISBN 1-929007-60-4)

Selected articles

 * Beyzarov E. Understanding Migraine Headaches. Pharmacy Times, August 16, 2012.
 * Beyzarov E. The Impact of Common Neuropsychiatric Conditions on Cognitive Function. Pharmacy Times Office of Continuing Professional Education CE activity.April 5, 2012
 * Beyzarov E. Preemptive Action: Reducing the Risk of Breast Cancer, Pharmacy Times Online Publishing, Beyzarov E. June 14, 2012
 * Beyzarov E. Opioid Dependence Hits Maternity Wards and NICUs, Pharmacy Times Online Publishing, June 12, 2012
 * Beyzarov E. The Anticholinergic Cognitive Burden, Pharmacy Times Online Publishing, April 9, 2012
 * Beyzarov E.(Co-author) Panic Over Japan’s Nuclear Crisis Hits U.S. (co-author), Pharmacy Practice News. VOLUME: 38,  March 11, 2011
 * Beyzarov E.(Co-author) Clinical and Economic Impact of Intra- and Postoperative Use of Opioids and Analgesic Devices. Hospital Pharmacy, Thomas Land Publishers Inc., June 2, 2011
 * Beyzarov E. (Co-author), Clinical Challenges and Considerations in Treating Bone Related Diseases. CME Supplement to Clinical Geriatrics. June 2010
 * Beyzarov, E. Hypertension: So many treatments, yet so undermanaged. Drug Topics. January 28, 2008
 * Beyzarov, E. 2008 pharmaceutical forecast report. Drug Topics. December. 2007
 * Beyzarov, E. New and improved version of phosphate binder approved for dialysis patients. Drug Topics. December. 2007
 * Beyzarov, E. New report offers guide to brain injuries. Drug Topics. Jan 8, 2007
 * Beyzarov, E. Hearts Discontent: Studies of promising heart failure treatments bring disappointment. Drug Topics. May 21, 2007
 * Beyzarov, E. How safe are compounded drugs? Drug Topics. Sep 18, 2006
 * Beyzarov, E. Opioids Can Disrupt Sleep and Contribute To Depression, Pain. Clinical Oncology, ISSUE: NOVEMBER 2006 | VOLUME: 01:02,
 * Beyzarov, E. This antiviral offers new option to HIV patients. Drug Topics. Aug 7, 2006
 * Beyzarov, E. A safer colon cleansing? Drug Topics. Jul 24, 2006
 * Beyzarov, E. High Rate of Errors Found In Pediatric Chemotherapy for ALL, Clinical Oncology, NOVEMBER 2006 | VOLUME: 01:02
 * Beyzarov, E. Self-Care May Be Best Path Toward Drug Compliance. Pharmacy Practice News. ISSUE: NOVEMBER 2006 | VOLUME: 33:11
 * Beyzarov, E. (Co-author) Use of Filgrastim Among Febrile Inpatients who Received outpatient Filgrastim or Pegfilgrastim. Hospital Pharmacy, Volume 41, Number 3, March 2006, pp 260–264
 * Beyzarov, E. New hope for Parkinson’s disease. Drug Topics. Aug 8, 2005
 * Beyzarov, E. New oral agent for lung cancer offers survival benefit . Drug Topics. Dec 13, 2004
 * Beyzarov, E. Arresting Angina. Drug Topics. Sept 27, 2004
 * Beyzarov, E. New guidelines set ambitious goals for lowering cholesterol. Drug Topics. Aug 9, 2004
 * Beyzarov, E. Palliative care: New guide offers directions. Drug Topics. Jul 26, 2004
 * Beyzarov, E. New guide hopes to stabilize bipolar depression management. Drug Topics. Jun 21, 2004
 * Beyzarov, E. New tool helps identify patients at risk for opioid abuse. Drug Topics. Jun 21, 2004
 * Beyzarov, E. USP issues new standards on blood products. Drug Topics. May 17, 2004
 * Beyzarov, E. New Data Underscore Risks of Lorazepam-Associated Propylene Glycol Toxicity. Pharmacy Practice News, VOLUME: 31:12,December 4, 2004,
 * Beyzarov, E. Warnings on Avastin Spur Reevaluation of Risks, Benefits. Pharmacy Practice News. ISSUE: NOVEMBER 2004 | VOLUME: 31:11
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000
 * Beyzarov, E. New hope for Parkinson’s disease. Drug Topics. Aug 8, 2005
 * Beyzarov, E. New oral agent for lung cancer offers survival benefit . Drug Topics. Dec 13, 2004
 * Beyzarov, E. Arresting Angina. Drug Topics. Sept 27, 2004
 * Beyzarov, E. New guidelines set ambitious goals for lowering cholesterol. Drug Topics. Aug 9, 2004
 * Beyzarov, E. Palliative care: New guide offers directions. Drug Topics. Jul 26, 2004
 * Beyzarov, E. New guide hopes to stabilize bipolar depression management. Drug Topics. Jun 21, 2004
 * Beyzarov, E. New tool helps identify patients at risk for opioid abuse. Drug Topics. Jun 21, 2004
 * Beyzarov, E. USP issues new standards on blood products. Drug Topics. May 17, 2004
 * Beyzarov, E. New Data Underscore Risks of Lorazepam-Associated Propylene Glycol Toxicity. Pharmacy Practice News, VOLUME: 31:12,December 4, 2004,
 * Beyzarov, E. Warnings on Avastin Spur Reevaluation of Risks, Benefits. Pharmacy Practice News. ISSUE: NOVEMBER 2004 | VOLUME: 31:11
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000
 * Beyzarov, E. New tool helps identify patients at risk for opioid abuse. Drug Topics. Jun 21, 2004
 * Beyzarov, E. USP issues new standards on blood products. Drug Topics. May 17, 2004
 * Beyzarov, E. New Data Underscore Risks of Lorazepam-Associated Propylene Glycol Toxicity. Pharmacy Practice News, VOLUME: 31:12,December 4, 2004,
 * Beyzarov, E. Warnings on Avastin Spur Reevaluation of Risks, Benefits. Pharmacy Practice News. ISSUE: NOVEMBER 2004 | VOLUME: 31:11
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000
 * Beyzarov, E. New Data Underscore Risks of Lorazepam-Associated Propylene Glycol Toxicity. Pharmacy Practice News, VOLUME: 31:12,December 4, 2004,
 * Beyzarov, E. Warnings on Avastin Spur Reevaluation of Risks, Benefits. Pharmacy Practice News. ISSUE: NOVEMBER 2004 | VOLUME: 31:11
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000
 * Beyzarov, E. The Migraine Menace. Drug Topics.  Vol. 144, No. 21,  November 6, 2000